Department of Gastroenterology, Beijing Friendship Hospital, Capital Medical University; National Clinical Research Center for Digestive Diseases; Beijing Digestive Disease Center; Beijing Key Laboratory for Precancerous Lesion of Digestive Diseases, Beijing, 100050, China.
Clinical Epidemiology and EBM Unit, Beijing Friendship Hospital, Capital Medical University; National Clinical Research Center for Digestive Disease, Beijing, 100050, China.
Sci Rep. 2020 Feb 13;10(1):2582. doi: 10.1038/s41598-020-58900-z.
Gastric hyperplastic polyps (GHPs) have a potential risk of neoplastic transformation, but the responsible mechanisms have not yet been established. We conducted a study involving 55 patients (33 female) who had undergone endoscopic or surgical resection of GHPs. We compared 16 patients who had GHPs showing neoplastic transformation with 39 patients who had non-neoplastic GHPs. We analyzed differences in serology, gastroscopic manifestations and pathology between the two groups in order to establish risk factors that may be associated with neoplastic transformation. The mean age of the cohort was 61.73 ± 9.024 years. The prevalence of positive serum gastric parietal cell antibody (PCA) was 61.8%. 30 of the GHPs with neoplastic formation had a "strawberry-like" appearance with erosions of polyps (P = 0.000). A history of anaemia was a risk factor for GHPs which demonstrated neoplastic transformation (odds ratio [OR], 3.729; 95% confidence interval [CI], 1.099-12.649; P = 0.035). Although the differences were not significant, our data showed higher prevalences of positive serum PCA (P = 0.057), hypergastrinemia (P = 0.062) and female gender (P = 0.146) in the GHP patients who had neoplastic transformation. Multiple polyps in the corpus (P = 0.024) occurred more frequently in serum PCA positive patients. Hypergastrinemia occurred more frequently in Helicobacter pylori negative patients and of these 20/22 patients had a positive PCA (P = 0.007). GHPs are associated with autoimmune metaplastic atrophic gastritis (AMAG). AMAG is probably one of the risk factors for GHPs to undergo neoplastic transformation.
胃增生性息肉(GHPs)有发生肿瘤性转化的潜在风险,但相关机制尚未确定。我们对 55 名(33 名女性)接受 GHPs 内镜或手术切除的患者进行了一项研究。我们比较了 16 名 GHPs 发生肿瘤性转化的患者和 39 名 GHPs 未发生肿瘤性转化的患者。我们分析了两组之间的血清学、胃镜表现和病理学差异,以确定可能与肿瘤性转化相关的危险因素。该队列的平均年龄为 61.73±9.024 岁。阳性血清壁细胞抗体(PCA)的患病率为 61.8%。30 个有肿瘤形成的 GHPs 呈“草莓状”,伴有息肉糜烂(P=0.000)。贫血史是 GHPs 发生肿瘤性转化的危险因素(比值比[OR],3.729;95%置信区间[CI],1.099-12.649;P=0.035)。虽然差异无统计学意义,但我们的数据显示,在发生肿瘤性转化的 GHP 患者中,阳性血清 PCA(P=0.057)、高胃泌素血症(P=0.062)和女性(P=0.146)的患病率较高。胃体多发性息肉(P=0.024)在血清 PCA 阳性患者中更为常见。幽门螺杆菌阴性患者中更常发生高胃泌素血症,其中 20/22 例患者 PCA 阳性(P=0.007)。GHPs 与自身免疫性多灶性萎缩性胃炎(AMAG)相关。AMAG 可能是 GHPs 发生肿瘤性转化的危险因素之一。